Tim Eckmanns
Impact in
- Applied Microbiology and Biotechnology top 0.01%
- Antibiotic Use and Resistance
- Molecular Medicine top 0.02%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 44
-
- Antimicrobial Resistance in Staphylococcus 27
- Clostridium difficile and Clostridium perfringens research 15
- Co-authors
- Robby Markwart (13 shared papers)Petra Gastmeier (20 shared papers)Olaniyi Ayobami (10 shared papers)Sebastian Haller (40 shared papers)Henning Rüden (19 shared papers)Thomas Harder (13 shared papers)Niklas Willrich (18 shared papers)Muna Abu Sin (29 shared papers)
- Journals
- Eurosurveillance (27 papers)Antimicrobial Resistance and Infection Control (10 papers)PLoS ONE (7 papers)Journal of Hospital Infection (7 papers)BMC Infectious Diseases (7 papers)
- Partner nations
- GermanySwedenUnited Kingdom
In The Last Decade
Tim Eckmanns
228 papers receiving 22.4k citations
Tim Eckmanns's Hit Papers
Peers
Comparison fields: 5 of 205
- Applied Microbiology and Biotechnology 4.4k
- Molecular Medicine 5.7k
- Clinical Biochemistry 1.7k
- Microbiology 1.5k
- Infectious Diseases 4.0k
Countries citing papers authored by Tim Eckmanns
This map shows the geographic impact of Tim Eckmanns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Eckmanns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Eckmanns more than expected).
Fields of papers citing papers by Tim Eckmanns
This network shows the impact of papers produced by Tim Eckmanns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Eckmanns. The network helps show where Tim Eckmanns may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim Eckmanns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 243 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis Hit paper breakdown → | 2022 | 11065 |
| 2 | Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis Hit paper breakdown → | 2018 | 2392 |
| 3 | Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 Hit paper breakdown → | 2024 | 1851 |
| 4 | Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study Hit paper breakdown → | 2016 | 489 |
| 5 | Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis Hit paper breakdown → | 2021 | 291 |
| 6 | Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 279 |
| 7 | Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis Hit paper breakdown → | 2020 | 262 |
| 8 | 2008 | 254 | |
| 9 | 2006 | 225 | |
| 10 | 2017 | 194 | |
| 11 | 2014 | 191 | |
| 12 | 2020 | 169 | |
| 13 | 2016 | 164 | |
| 14 | 2021 | 144 | |
| 15 | 2020 | 134 | |
| 16 | 2019 | 130 | |
| 17 | 2022 | 128 | |
| 18 | 2020 | 122 | |
| 19 | 2012 | 116 | |
| 20 | 2013 | 114 |
About Tim Eckmanns
Tim Eckmanns is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Molecular Medicine, Clinical Biochemistry and Epidemiology, having authored 243 papers that have together received 23.0k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (44 papers), Antibiotic Resistance in Bacteria (36 papers), Antimicrobial Resistance in Staphylococcus (27 papers), Bacterial Identification and Susceptibility Testing (27 papers), Clostridium difficile and Clostridium perfringens research (15 papers), Urinary Tract Infections Management (13 papers), COVID-19 epidemiological studies (11 papers) and Nosocomial Infections in ICU (11 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (4.4k citations), Molecular Medicine (5.7k citations), Clinical Biochemistry (1.7k citations), Microbiology (1.5k citations) and Infectious Diseases (4.0k citations). Tim Eckmanns has collaborated with scholars based in Germany, Sweden and United Kingdom. Frequent co-authors include Robby Markwart, Petra Gastmeier, Olaniyi Ayobami, Sebastian Haller, Henning Rüden, Thomas Harder, Niklas Willrich, Muna Abu Sin, Alessandro Cassini and Edward Velasco. Their work appears in journals such as Eurosurveillance, Antimicrobial Resistance and Infection Control, PLoS ONE, Journal of Hospital Infection and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.